|
||
World Equity NewsEquities Org UKMortgages, insurance, and loans for the self-employed and students Equities Org equities news has moved! How to quickly sell your house London equity markets make small gains Eurofirst highest since May 2002 Eurofirst makes small gains as Xetra Dax down Eurofirst slightly higher as elections approach London strong on double witching hour NYSE sees little movement on investor caution European equities investors worried by elections NYSE equities down on economic data Nikkei down on post-election profit-taking Nikkei down on post-election profit-taking Economic concerns hit Eurofirst and Xetra Dax Japanese elections boost Tokyo indices Xetra Dax sees fall in Allianz Utilities focus on FTSE Dow Jones sees little movement Analysts suggest Katrina will stimulate economy Investors settled by Japanese polls Banking and utilities see gains on Eurofirst FTSE makes small gains on mergers Investors consider construction boom after hurricane Investors wait in Sunday's election Eurofirst drops from 38-month highs UK Equities down despite monetary policy decision London FTSE makes only small gains Investors consider Katrina economy impact FTSE gains to three-year high |
27/05/05Pfizer faces FDA over viagra sight losss claimsThe US Food and Drug Administration has confirmed that it investigating reports that up to 38 men who used the impotence drug Viagra have suffered vision loss. Pfizer, the company that makes Viagra and the largest pharmaceuticals group in the world, defended its product, saying that there is no evidence that the type of vision loss reported in the Viagra users is more frequent in users of the drug than it is in men who do not use it. The company also said that the type of vision loss being reported by users of the drug is common in men over 50 who have conditions like high blood pressure, high cholesterol, and diabetes, conditions that can also cause the impotence problems that Viagra treats. This, Pfizer claims, makes it impossible to tell whether the drug itself had anything to do with the men’s loss of vision. Notwithstanding their defense of Viagra, Pfizer is in talks with the FDA over the possibility of revising safety warnings on the drug. Shares of Pfizer lost nearly 2 percent of their value on the New York Stock Exchange Friday after reports of the vision problems were announced. |
USA equity market references:CategoriesArchives
Morocco property investment
Property investment opportunities available in Morocco.
SDH Flannel
Find great deals on SDH bedding products.
sell and rent back
Find how to sell and rent back your property.
Corner shower
Discounted corner showers & bath accessories
Technical schools
Find business and tech school course for you
|
|
US Equities copyright 2005 Central Consultants : All Rights Reserved |
||